Vascular endothelial growth factor genetic polymorphisms and haplotypes in women with migraine

DNA and Cell Biology

Volumn 29, Issue 7, 2010, Pages 357-362

  Gonçalves, Flavia M ^a   Martins Oliveira, Alisson ^b   Speciali, Jose G ^b   Izidoro Toledo, Tatiane C ^b   Luizon, Marcelo R ^b   Dach, Fabiola ^b   Tanus Santos, Jose E ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; ETHNICITY; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; GROUPS BY AGE; HAPLOTYPE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MIGRAINE; PRIORITY JOURNAL; SMOKING; WOMEN'S HEALTH;

ALLELES; FEMALE; GENE THERAPY; GENOTYPE; HAPLOTYPES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MIGRAINE DISORDERS; POLYMORPHISM, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 77954927649     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2010.1025     Document Type: Article

References (46)

1. Awata, T., Inoue, K., Kurihara, S., Ohkubo, T., Watanabe, M., Inukai, K., Inoue, I., and Katayama, S. (2002). A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 51, 1635-1639.
2. Bates, D.O., and Harper, S.J. (2002). Regulation of vascular permeability by vascular endothelial growth factors. Vascul Pharmacol 39, 225-237.
3. Bigal, M.E., Kurth, T., Hu, H., Santanello, N., and Lipton, R.B. (2009). Migraine and cardiovascular disease: possible mechanisms of interaction. Neurology 72, 1864-1871.
4. Biselli, P.M., Guerzoni, A.R., de Godoy, M.F., Pavarino-Bertelli, E.C., and Goloni-Bertollo, E.M. (2008). Vascular endothelial growth factor genetic variability and coronary artery disease in Brazilian population. Heart Vessels 23, 371-375.
5. Churchill, A.J., Carter, J.G., Ramsden, C., Turner, S.J., Yeung, A., Brenchley, P.E., and Ray, D.W. (2008). VEGF polymorphisms are associated with severity of diabetic retinopathy. Invest Ophthalmol Vis Sci 49, 3611-3616.
6. Crawford, D.C., and Nickerson, D.A. (2005). Definition and clinical importance of haplotypes. Annu Rev Med 56, 303-320.
7. Del Bo, R., Scarlato, M., Ghezzi, S., Martinelli Boneschi, F., Feno-glio, C., Galbiati, S., Virgilio, R., Galimberti, D., Galimberti, G., Crimi, M., Ferrarese, C., Scarpini, E., Bresolin, N., and Comi, G.P. (2005). Vascular endothelial growth factor gene variability is associated with increased risk for AD. Ann Neurol 57, 373-380.
8. Douvaras, P., Antonatos, D.G., Kekou, K., Patsilinakos, S., Chouliaras, G., Christou, A., Andrikou, A., and Kanavakis, E. (2009). Association of VEGF gene polymorphisms with the development of heart failure in patients after myocardial infarction. Cardiology 114, 11-18.
9. Facemire, C.S., Nixon, A.B., Griffiths, R., Hurwitz, H., and Coffman, T.M. (2009). Vascular endothelial growth factor receptor 2 controls blood pressure by regulating nitric oxide synthase expression. Hypertension 54, 652-658.
10. Ferrara, N. (2009). Vascular endothelial growth factor. Arter-ioscler Thromb Vasc Biol 29, 789-791.
11. Ferrara, N., Gerber, H.P., and LeCouter, J. (2003). The biology of VEGF and its receptors. Nat Med 9, 669-676.
12. Goadsby, P.J. (2009). Pathophysiology of migraine. Neurol Clin 27, 335-360.
13. Gruber, H.J., Bernecker, C., Lechner, A., Weiss, S., Wallner-Blazek, M., Meinitzer, A., Hobarth, G., Renner, W., Fauler, G., Horejsi, R., Fazekas, F., and Truschnig-Wilders, M. (2010). Increased nitric oxide stress is associated with migraine. Cephalalgia 30, 486-492.
14. Headache Classification Subcommittee of the International Headache Society (2004). The international classification of headache disorders: 2nd edition. Cephalalgia 24 Suppl 1, 9-160.
15. Ho, Q.T., and Kuo, C.J. (2007). Vascular endothelial growth factor: biology and therapeutic applications. Int J Biochem Cell Biol 39, 1349-1357.
16. Holmes, D.I., and Zachary, I. (2005). The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease. Genome Biol 6, 209.
17. Howell, W.M., Ali, S., Rose-Zerilli, M.J., and Ye, S. (2005). VEGF polymorphisms and severity of atherosclerosis. J Med Genet 42, 485-490.
18. Kalaria, R.N., Cohen, D.L., Premkumar, D.R., Nag, S., LaManna, J.C., and Lust, W.D. (1998). Vascular endothelial growth factor in Alzheimer's disease and experimental cerebral ischemia. Brain Res Mol Brain Res 62, 101-105.
19. Kurth, T. (2007). Migraine and ischaemic vascular events. Cephalalgia 27, 965-975.
20. Kurth, T., Gaziano, J.M., Cook, N.R., Logroscino, G., Diener, H.C., and Buring, J.E. (2006). Migraine and risk of cardiovascular disease in women. JAMA 296, 283-291.
21. Lambrechts, D., Storkebaum, E., Morimoto, M., Del-Favero, J., Desmet, F., Marklund, S.L., Wyns, S., Thijs, V., Andersson, J., van Marion, I., Al-Chalabi, A., Bornes, S., Musson, R., Hansen, V., Beckman, L., Adolfsson, R., Pall, H.S., Prats, H., Vermeire, S., Rutgeerts, P., Katayama, S., Awata, T., Leigh, N., Lang-Lazdunski, L., Dewerchin, M., Shaw, C., Moons, L., Vlietinck, R., Morrison, K.E., Robberecht, W., Van Broeckhoven, C., Collen, D., Andersen, P.M., and Carmeliet, P. (2003). VEGF is a modifier of amyotrophic lateral sclerosisinmice and humans and protects motoneurons against ischemic death. Nat Genet 34, 383-394.
22. Lipton, R.B., Stewart, W.F., Diamond, S., Diamond, M.L., and Reed, M. (2001). Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 41, 646-657.
23. Loureiro, R.M., and D'Amore, P.A. (2005). Transcriptional regulation of vascular endothelial growth factor in cancer. Cyto-kine Growth Factor Rev 16, 77-89.
24. Martins-Oliveira, A., Speciali, J.G., Dach, F., Marcaccini, A.M., Goncalves, F.M., Gerlach, R.F., and Tanus-Santos, J.E. (2009). Different circulating metalloproteinases profiles in women with migraine with and without aura. Clin Chim Acta 408, 60-64.
25. Moskowitz, M.A. (2007). Pathophysiology of headache\past and present. Headache 47 Suppl 1, S58-S63.
26. Muniz, J.J., Izidoro-Toledo, T.C., Metzger, I.F., Sandrim, V.C., and Tanus-Santos, J.E. (2009). Interethnic differences in the distribution of clinically relevant vascular endothelial growth factor genetic polymorphisms. DNA Cell Biol 28, 567-572.
27. Nagy, J.A., Dvorak, A.M., and Dvorak, H.F. (2007). VEGF-A and the induction of pathological angiogenesis. Annu Rev Pathol 2, 251-275.
28. Olesen, J. (2008). The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache. Pharmacol Ther 120, 157-171.
29. Otrock, Z.K., Makarem, J.A., and Shamseddine, A.I. (2007). Vascular endothelial growth factor family of ligands and receptors: review. Blood Cells Mol Dis 38, 258-268.
30. Pietrobon, D., and Striessnig, J. (2003). Neurobiology of migraine. Nat Rev Neurosci 4, 386-398.
31. Pugh, C.W., and Ratcliffe, P.J. (2003). Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 9, 677-684.
32. Roy, H., Bhardwaj, S., and Yla-Herttuala, S. (2006). Biology of vascular endothelial growth factors. FEBS Lett 580, 2879-2887.
33. Ruiz de Almodovar, C., Lambrechts, D., Mazzone, M., and Carmeliet, P. (2009). Role and therapeutic potential of VEGF in the nervous system. Physiol Rev 89, 607-648.
34. Samii, A., Unger, J., and Lange, W. (1999). Vascular endothe-lial growth factor expression in peripheral nerves and dorsal root ganglia in diabetic neuropathy in rats. Neurosci Lett 262, 159-162.
35. Sandrim, V.C., Coelho, E.B., Nobre, F., Arado, G.M., Lanchote, V.L., and Tanus-Santos, J.E. (2006). Susceptible and protective eNOS haplotypes in hypertensive black and white subjects. Atherosclerosis 186, 428-432.
36. Sandrim, V.C., de Syllos, R.W., Lisboa, H.R., Tres, G.S., and Tanus-Santos, J.E. (2007). Influence of eNOS haplotypes on the plasma nitric oxide products concentrations in hypertensive and type 2 diabetes mellitus patients. Nitric Oxide 16, 348-355.
37. Sandrim, V.C., Palei, A.C., Cavalli, R.C., Araujo, F.M., Ramos, E.S., Duarte, G., and Tanus-Santos, J.E. (2008). eNOS haplo-types associated with gestational hypertension or preeclamp-sia. Pharmacogenomics 9, 1467-1473.
38. Sandrim, V.C., Palei, A.C., Cavalli, R.C., Araujo, F.M., Ramos, E.S., Duarte, G., and Tanus-Santos, J.E. (2009). Vascular endo-thelial growth factor genotypes and haplotypes are associated with pre-eclampsia but not with gestational hypertension. Mol Hum Reprod 15, 115-120.
39. Schaid, D.J., Rowland, C.M., Tines, D.E., Jacobson, R.M., and Poland, G.A. (2002). Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70, 425-434.
40. Scharfman, H.E., and MacLusky, N.J. (2008). Estrogen-growth factor interactions and their contributions to neurological disorders. Headache 48 Suppl 2, S77-S89.
41. Shahbazi, M., Fryer, A.A., Pravica, V., Brogan, I.J., Ramsay, H.M., Hutchinson, I.V., and Harden, P.N. (2002). Vascular endo-thelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol 13, 260-264.
42. Silberstein, S.D. (2004). Migraine. Lancet 363, 381-391.
43. Stevens, A., Soden, J., Brenchley, P.E., Ralph, S., and Ray, D.W. (2003). Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res 63, 812-816.
44. Sun, Y., Jin, K., Xie, L., Childs, J., Mao, X.O., Logvinova, A., and Greenberg, D.A. (2003). VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest 111, 1843-1851.
45. Tsai, S.J., Hong, C.J., Liou, Y.J., Chen, T.J., Chen, M.L., Hou, S.J., Yen, F.C., and Yu, Y.W. (2009). Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder. Psychiatry Res 169, 113-117.
46. Watson, C.J., Webb, N.J., Bottomley, M.J., and Brenchley, P.E. (2000). Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 12, 1232-1235.